FEI Announces Agreement to Acquire DCG Systems
News Nov 03, 2015
FEI Company and DCG Systems, Inc. have announced a definitive agreement under which FEI would acquire DCG for $160 million in an all cash transaction. DCG is a leading supplier of electrical fault characterization, localization and editing equipment, serving process development, yield ramp and failure analysis applications for a wide range of semiconductor and electronics manufacturers.
Headquartered in Fremont, California, DCG is a profitable private company and was the recipient of Deloitte’s Technology Fast 500 award in 2013 and 2014.
The deal combines FEI’s leading physical failure analysis capabilities for the semiconductor lab with DCG’s complementary portfolio of electrical failure analysis solutions. DCG’s offerings expand FEI’s served available market through the addition of optical imaging, thermal imaging and nano-probing technologies. The combined company’s solutions will offer a more complete workflow for customers as they deal with the increasing complexities from process development to advanced 3D packaging.
“The acquisition of DCG expands FEI’s presence and capability in the semiconductor lab and enhances our ability to provide a complete workflow solution,” commented Don Kania, president and CEO of FEI. “The combination brings together leaders in physical and electrical failure analysis and will enable our customers to better connect workflows to improve time to data and efficiency.”
“Together with FEI we have a tremendous opportunity to offer our customers an integrated defect analysis solution,” commented Israel Niv, CEO of DCG. “The DCG team is excited to join forces with FEI and tap into FEI’s strong global presence and significant R&D capabilities to drive further penetration of DCG’s leading electrical failure analysis solutions. We look forward to working together with FEI to provide integrated solutions to help our customers successfully execute on their future technology roadmaps.”
DCG generated revenue of $76 million in its fiscal year ended January 31, 2015. The transaction is expected to be slightly accretive to FEI’s 2016 GAAP EPS. FEI intends to fund the acquisition with cash on hand.
The transaction is expected to close by the end of 2015 and is subject to certain regulatory approvals and customary closing conditions.
Forensic Analysis Sheds Light on Ligament InjuriesNews
A team have used a forensic approach to reconstruct injuries by examining bone bruises on the knees of 15 men and 15 women with torn anterior cruciate ligaments (ACL). This showed while women are two to four times more likely than men to tear the ACL in their knee, the cause of this injury is no different between the sexes.READ MORE
Flavins Keep a Handy Helper in Their PocketNews
A team has now shown in detail how oxygen interacts with the flavin in an enzyme - revealing for the first time precisely how it works. Flavins play a key role in metabolic processes, in the immune system and in neural development in humans - and are equally important to bacteria, fungi and plants.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018